BioInfra Life Science Inc. (XKON:266470)
South Korea flag South Korea · Delayed Price · Currency is KRW
281.00
-9.00 (-3.10%)
At close: May 9, 2025, 3:30 PM KST

BioInfra Life Science Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2019 FY 2018 FY 2017 FY 2016
Period Ending
Dec '19 Dec '18 Dec '17 Dec '16
Operating Revenue
1,8751,5511,3701,550
Other Revenue
---0
Revenue
1,8751,5511,3701,550
Revenue Growth (YoY)
20.82%13.25%-11.60%-
Cost of Revenue
978.91723.68622.76662.63
Gross Profit
895.63827.76747.16887.05
Selling, General & Admin
2,9442,9922,7213,381
Research & Development
1,1151,162975.6941.9
Other Operating Expenses
21.8122.0920.522.44
Operating Expenses
4,2654,4423,8664,413
Operating Income
-3,369-3,614-3,119-3,526
Interest Expense
-205.65-27.2-60.16-55.3
Interest & Investment Income
140.74125.1976.52145.21
Currency Exchange Gain (Loss)
-2.3811.7-37.4243.17
Other Non Operating Income (Expenses)
80.69-343.4272.8819.79
EBT Excluding Unusual Items
-3,356-3,848-3,067-3,373
Gain (Loss) on Sale of Investments
77.276.07--
Gain (Loss) on Sale of Assets
--35.41-112.69-55.59
Asset Writedown
---816.23-1,175
Pretax Income
-3,278-3,807-3,996-4,603
Net Income
-3,278-3,807-3,996-4,603
Net Income to Common
-3,278-3,807-3,996-4,603
Shares Outstanding (Basic)
13141313
Shares Outstanding (Diluted)
13141313
Shares Change (YoY)
-1.87%6.28%1.42%-
EPS (Basic)
-243.11-277.01-309.00-361.00
EPS (Diluted)
-243.11-277.01-309.00-361.00
Free Cash Flow
-2,989-4,112-3,607-3,760
Free Cash Flow Per Share
-221.65-299.20-278.95-294.93
Gross Margin
47.78%53.35%54.54%57.24%
Operating Margin
-179.72%-232.93%-227.65%-227.50%
Profit Margin
-174.89%-245.38%-291.67%-297.02%
Free Cash Flow Margin
-159.45%-265.03%-263.31%-242.66%
EBITDA
-3,022-3,341-2,940-3,398
EBITDA Margin
-161.21%-215.33%-214.63%-219.25%
D&A For EBITDA
347.07273.1178.4127.89
EBIT
-3,369-3,614-3,119-3,526
EBIT Margin
-179.72%-232.93%-227.65%-227.50%
Advertising Expenses
62.5147.747.0553.05
Updated May 19, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.